EXCHANGE TRADED CONCEPTS, LLC - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 166 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.

Quarter-by-quarter ownership
EXCHANGE TRADED CONCEPTS, LLC ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q2 2023$654,976
+5.4%
26,7010.0%0.02%
-5.9%
Q1 2023$621,332
-49.6%
26,701
-45.1%
0.02%
-51.4%
Q4 2022$1,231,610
+35.3%
48,661
+3.1%
0.04%
+16.7%
Q3 2022$910,000
+10011.1%
47,181
+27491.2%
0.03%
Q1 2021$9,0001710.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q2 2021
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$36,281,23432.04%
SB INVESTMENT ADVISERS (UK) LTD 18,319,938$426,304,9573.50%
Zebra Capital Management LLC 27,110$6313.15%
Avidity Partners Management LP 1,640,200$38,167,4541.27%
Sofinnova Investments, Inc. 657,559$15,301,3980.98%
DCF Advisers, LLC 62,000$1,442,7400.88%
SECTOR GAMMA AS 145,545$3,386,8320.82%
Temasek Holdings (Private) Ltd 5,814,972$135,314,3980.80%
BRAIDWELL LP 604,036$14,055,9180.46%
SummerHaven Investment Management, LLC 26,045$606,0670.35%
View complete list of VIR BIOTECHNOLOGY INC shareholders